mefloquine has been researched along with Deficiency of Glucose-6-Phosphate Dehydrogenase in 10 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (20.00) | 18.2507 |
| 2000's | 1 (10.00) | 29.6817 |
| 2010's | 7 (70.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Choi, L; Garner, P; Gelband, H; Graves, PM | 1 |
| Amnuaysirikul, J; Caridha, D; Gao, X; Grogl, M; Hickman, M; Ishida, H; Li, Q; Magill, AJ; O'Neil, MT; Ohrt, C; Ray, P; Weina, PJ; Zhang, P | 1 |
| Baresel, PC; Campo, B; Magill, AJ; Ohrt, C; Rochford, R; Sampath, A; Tekwani, BL; Walker, LA | 1 |
| Garner, P; Gelband, H; Graves, PM | 3 |
| Alifrangis, M; Baraka, V; Carneiro, I; Chandramohan, D; Gesase, S; Gosling, R; Hashim, R; Ishengoma, D; Mosha, J; Poirot, E; Vittinghoff, E | 1 |
| Drent, M | 1 |
| Ambroise-Thomas, P; Barro, C; Brenier-Pinchart, MP; Brion, JP; Issartel, B; Pinel, C | 1 |
| Contini, C; Cultrera, R | 1 |
4 review(s) available for mefloquine and Deficiency of Glucose-6-Phosphate Dehydrogenase
| Article | Year |
|---|---|
Primaquine or other 8-aminoquinolines for reducing Plasmodium falciparum transmission.
Topics: Adult; Antimalarials; Artemisinins; Child; Chloroquine; Drug Combinations; Glucosephosphate Dehydrogenase Deficiency; Humans; Malaria, Falciparum; Mefloquine; Non-Randomized Controlled Trials as Topic; Plasmodium falciparum; Primaquine; Pyrimethamine; Quinine; Randomized Controlled Trials as Topic; Sulfadoxine; Time Factors | 2018 |
Primaquine or other 8-aminoquinoline for reducing P. falciparum transmission.
Topics: Antimalarials; Artemisinins; Artesunate; Chloroquine; Drug Combinations; Glucosephosphate Dehydrogenase Deficiency; Humans; Malaria, Falciparum; Mefloquine; Plasmodium falciparum; Primaquine; Pyrimethamine; Quinine; Randomized Controlled Trials as Topic; Sulfadoxine | 2014 |
Primaquine or other 8-aminoquinoline for reducing Plasmodium falciparum transmission.
Topics: Antimalarials; Artemisinins; Artesunate; Chloroquine; Drug Combinations; Glucosephosphate Dehydrogenase Deficiency; Humans; Malaria, Falciparum; Mefloquine; Plasmodium falciparum; Primaquine; Pyrimethamine; Quinine; Randomized Controlled Trials as Topic; Sulfadoxine | 2015 |
Primaquine for reducing Plasmodium falciparum transmission.
Topics: Antimalarials; Artemisinins; Artesunate; Chloroquine; Drug Combinations; Glucosephosphate Dehydrogenase Deficiency; Humans; Malaria, Falciparum; Mefloquine; Plasmodium falciparum; Primaquine; Pyrimethamine; Quinine; Randomized Controlled Trials as Topic; Sulfadoxine | 2012 |
1 trial(s) available for mefloquine and Deficiency of Glucose-6-Phosphate Dehydrogenase
| Article | Year |
|---|---|
Risks of Hemolysis in Glucose-6-Phosphate Dehydrogenase Deficient Infants Exposed to Chlorproguanil-Dapsone, Mefloquine and Sulfadoxine-Pyrimethamine as Part of Intermittent Presumptive Treatment of Malaria in Infants.
Topics: Antimalarials; Cohort Studies; Dapsone; Double-Blind Method; Drug Combinations; Female; Genotype; Glucosephosphate Dehydrogenase; Glucosephosphate Dehydrogenase Deficiency; Hemoglobins; Hemolysis; Humans; Infant; Logistic Models; Malaria; Male; Mefloquine; Multivariate Analysis; Odds Ratio; Poisson Distribution; Polymorphism, Single Nucleotide; Proguanil; Pyrimethamine; Sulfadoxine; Tanzania | 2015 |
5 other study(ies) available for mefloquine and Deficiency of Glucose-6-Phosphate Dehydrogenase
| Article | Year |
|---|---|
An in vivo drug screening model using glucose-6-phosphate dehydrogenase deficient mice to predict the hemolytic toxicity of 8-aminoquinolines.
Topics: Acute Disease; Aminoquinolines; Anemia, Hemolytic; Animals; Antimalarials; Chloroquine; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Genotype; Glucosephosphate Dehydrogenase Deficiency; Glutathione; Haptoglobins; Hemolytic Agents; Male; Mefloquine; Mice; Phenotype; Primaquine; Reticulocyte Count | 2013 |
Humanized mouse model of glucose 6-phosphate dehydrogenase deficiency for in vivo assessment of hemolytic toxicity.
Topics: Aminoquinolines; Anemia, Hemolytic; Animals; Antimalarials; Chloroquine; Combined Modality Therapy; Dapsone; Dose-Response Relationship, Drug; Doxycycline; Drug Evaluation, Preclinical; Erythrocyte Count; Erythrocyte Transfusion; Female; Glucosephosphate Dehydrogenase Deficiency; Humans; Mefloquine; Mice; Mice, Inbred NOD; Mice, SCID; Primaquine; Pyrimethamine; Reproducibility of Results; Sensitivity and Specificity; Transplantation, Heterologous | 2013 |
Drug-induced pneumonia associated with hemizygote glucose-6-phosphate-dehydrogenase deficiency.
Topics: Antimalarials; Glucosephosphate Dehydrogenase Deficiency; Humans; Malaria; Male; Mefloquine; Middle Aged; Pneumonia | 1998 |
[Glucose-6-phosphate dehydrogenase deficiency and hemoglobinuric biliary fever after taking mefloquine].
Topics: Adult; Bile Duct Diseases; Fever; Glucosephosphate Dehydrogenase Deficiency; Hemoglobinuria; Humans; Male; Mefloquine; Splenomegaly | 2000 |
Management of a case of chloroquine-resistant falciparum malaria in a pregnant woman with glucose-6-phosphate dehydrogenase (G6PD) deficiency.
Topics: Adult; Animals; Antimalarials; Chloroquine; Drug Resistance, Microbial; Drug Therapy, Combination; Female; Glucosephosphate Dehydrogenase Deficiency; Humans; Malaria, Falciparum; Mefloquine; Microbial Sensitivity Tests; Pregnancy; Pregnancy Complications; Pregnancy Outcome; Pyrimethamine | 1999 |